Research Tools

A/F Protein Inc.

Brief Description

A/F Protein Inc. is the world's only commercial producer of antifreeze proteins purified from natural sources for sale to the research and development community. The company was spun out of discoveries in the lab of UC Berkeley Professor of Bioengineering and Mechanical Engineering Boris Rubinsky, an expert in the field of ice physics. Dr. Rubinsky reported on the ability of antifreeze proteins and glycoproteins to interact with mammalian cell membranes at hypothermic temperatures and protect such cells from depolarization and death. This important finding has led to...

Ergodicity

Brief Description

Ergodicity develops analytical methods for the age of AI. The company takes a data-first approach to create next-generation optical tools that set new standards in the accessibility of information in chemical and biophysical analytics for biotech.

Inventors

Hendrik Utzat

Company Founders

UC Berkeley Assistant Professor of Chemistry Hendrik Utzat and Richard Maceiczyk

Timeline 2025. Company founded

Water Harvesting, Inc

Brief Description Water Harvesting Inc. was formed in 2018 to commercialize atmospheric water harvesting systems based on metal organic frameworks (MOFs) and address the global challenge of water scarcity. MOFs work for atmospheric water harvesting even under very arid conditions. Inventors

Farhad Fathieh, Nikita Hanikel, Markus Kalmutzki, Ievgen Kapustin, Hao Lyu, Mathieu Steven Prevot, Omar Yaghi, JingJing Yang, Bing Zhang

Company Founders

Frank Ramirez (Berkeley Law, JD, 1979), Chris Kay, Eugene Kapustin (UC Berkeley PhD, 2018, Chemistry), David Kuo (UC Berkeley, MS, 1985, Ph.D...

Algen Biotechnologies

Brief Description

Algen Biotechnologies is building a next-generation, functional genomics-based platform for the discovery of novel therapeutics for cancers with high unmet need. Algen’s research group focuses on developing and applying novel functional genomics technologies to address scientific challenges in drug discovery. The company's biologists and data scientists are collaborating to deliver innovative, patient-centric medicines for the toughest-to-treat diseases.

The company was founded to commercialize technology developed at UC Berkeley while Algen Biotechnologies CEO...

Caribou Biosciences Inc.

Brief Description

Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company’s genome-editing platform, including its Cas12a chRDNA technology, enables superior precision to develop cell therapies that are armored to potentially improve activity against diseases. Caribou is advancing a pipeline of off-the-shelf cell therapies from its CAR-T cell platform as readily available treatments for patients with hematologic malignancies and autoimmune diseases.

...

Research Tools

Synvivia, Inc.

Brief Description

Synvivia is a synthetic biology company that optimizes cell behavior for gene therapy manufacturing, providing a practical solution for genetically encoded biocontainment. The company is building genetically encoded biocontainment technologies that will enable the widespread use of synthetic biology outside of the laboratory.

The company's technology was developed at UC Berkeley with grants from the NSF and DARPA. The work was published in ACS Synthetic Biology and featured as an Editor’s Choice in Science Magazine. Synvivia has exclusive license to the...

IMYu

Brief Description

Rejuvenation therapy based on a modified version of an already FDA-approved plasma exchange technique known as plasmapheresis, in which a machine separates the plasma (the liquid part of the blood) from the blood cells and then returns the blood to the person receiving treatment. The company's approach, called next gen-apheresis, promises to spur the rejuvenation of organs and tissues as people age.

Timeline 2019. Company founded Inventors

Irina Conboy, Michael Conboy, Wendy Cousin, Christian Elabd, Yutong Liu, Melod Mehdipour, David...

Acacia Biosciences, Inc.

Brief Description

Acacia Biosciences, Inc. was a drug discovery technology company committed to the creation of proprietary assay systems and databases that facilitate the rapid development of biopharmaceutical s and agricultural chemicals. The Genome Reporter Matrix is the first in a series of novel tools that provide practical analysis of early stage chemicals by interpreting their effects across entire genomes. In addition to the GRM, Acacia's technology is used to discover novel targets and gene regulatory mechanisms.

Acacia Biosciences merged with Rosetta Inpharmatics in 1999...